NGLY1 deficiency is a very rare genetic disorder caused by biallelic pathogenic variants in NGLY1. It is an autosomal recessive disorder. Errors in deglycosylation are responsible for the symptoms of this condition.[1] Clinically, most affected individuals display developmental delay, lack of tears, elevated liver transaminases and a movement disorder.[2] NGLY1 deficiency is difficult to diagnose, and most individuals have been identified by exome sequencing.
NGLY1 deficiency causes a dysfunction in the endoplasmic reticulum-associated degradation pathway. NGLY1 encodes an enzyme, N-glycanase 1, that cleaves N-glycans. Without N-glycanase, N-glycosylated proteins that are misfolded in the endoplasmic reticulum cannot be degraded, and thus accumulate in the cytoplasm of cells.[3][4]
^Online Mendelian Inheritance in Man (OMIM): CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG - 615273
^Lam C, Wolfe L, Need A, Shashi V, Enns G (February 2018). "NGLY1-Related Congenital Disorder of Deglycosylation". In Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJ, Stephens K, Amemiya A, Lam C, Wolfe L, Need A, Shashi V, Enns G (eds.). GeneReviews. Seattle (WA): University of Washington, Seattle. PMID 29419975.
^Freeze HH (March 2013). "Understanding human glycosylation disorders: biochemistry leads the charge". The Journal of Biological Chemistry. 288 (10): 6936–45. doi:10.1074/jbc.R112.429274. PMC 3591604. PMID 23329837.
^Enns GM, Shashi V, Bainbridge M, Gambello MJ, Zahir FR, Bast T, et al. (October 2014). "Mutations in NGLY1 cause an inherited disorder of the endoplasmic reticulum-associated degradation pathway". Genetics in Medicine. 16 (10): 751–8. doi:10.1038/gim.2014.22. PMC 4243708. PMID 24651605.
NGLY1deficiency is a very rare genetic disorder caused by biallelic pathogenic variants in NGLY1. It is an autosomal recessive disorder. Errors in deglycosylation...
advantageous for an efficient ERAD process. In 2012, NGLY1deficiency, involving mutations in the NGLY1 gene locus, was first identified through an exome...
Triple-A syndrome and NGLY1deficiency. Alacrima can be formally diagnosed through a Schirmer's test. "NGLY1 Foundation". NGLY1deficiency. Archived from the...
Grace Science Foundation in 2018. The foundation focuses on curing NGLY1deficiency through developing therapeutics that are efficient and inexpensive...
blog post that went viral after his son, Bertrand, was diagnosed with NGLY1deficiency, a rare disease that was previously unknown. This widespread publicity...